business strategy for industry >$20b + csl

For all those who have just found us - find below an extract from their Web Page..

Business Strategy

Patrys develops natural human antibody products
for the treatment of cancer. The Companys pipeline
includes lead products PAT-LM1 and PAT-SM6,
which are scheduled to enter the clinic in 2009,
and a number of other products being advanced by
larger industry partners.

The depth of Patrys product
pipeline facilitates a three-part business strategy:

Maximising opportunities for success. The
combination of internal and external programs
generates multiple opportunities for success, a
significant number of which are funded by larger
industry partners.

Targeting unmet medical needs. Patrys targets
cancers where the 5 year survival rate is less
than 20%, meaning there is considerable industry
demand for our products.

Exploiting competitive advantages in an
established industry. Patrys products offer
potential safety and potency benefits in the wellestablished
antibody sector where annual sales
now exceed US$20 billion.

Lets see what happens tomorrow - I expect a 35c+ Close and still I wont be selling.